Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) Using Flattening Filter Free (FFF) in Early Non-small Cell Lung Cancers (NSCLC) and Metastatic Lung Cancers.

Status

Recruiting

Phases

Phase 2

Study type

Observational

Source

TCTR

Registry ID

TCTR20171127003

Enrollment

138

Registered

2017-11-27

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early non&#45

Interventions

Patients with early NSCLC or lung metastases treated with SBRT using FFF in department of radiation oncology King Chulalongkorn Memorial Hospital since 2013.

Treatment

SBRT lung

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with early NSCLC or lung metastases treated with SBRT using FFF. 2. Adequate follow up period of more than 6 months after SBRT

Exclusion criteria

Exclusion criteria: 1. Incomplete documented medical records or inaccessible data 2. Incomplete treatment

Design outcomes

Primary

Measure	Time frame
1 years local control 01/12/2018 Retrospectively review medical records and radiation treatment planning and use case record forms.	—

Secondary

Measure	Time frame
overall survival 1/12/2018 Retrospectively review medical records and radiation treatment planning and use Case Record Form.	—

Countries

Thailand

Contacts

Public ContactThitiporn Taweesakulvashra

Faculty of medicine, Chulalongkorn university

pamm.thitiporn@gmail.com+66891406990

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) Using Flattening Filter Free (FFF) in Early Non&#45;small Cell Lung Cancers (NSCLC) and Metastatic Lung Cancers.